SCHEMBL6177675

SCHEMBL6177675

CNC(=O)C(c1ccnc(-c2ccc(OC)cc2)c1)N1C(=O)N(c2ccc(OC(F)(F)F)cc2)C(=O)C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.41
IGF1R P08069 2/20 0.38
MAT2A P31153 1/20 0.38
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ABL1 P00519 3/20 0.35
BCR P11274 2/20 0.35
KDM5A P29375 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
PDE2A O00408 3/20 0.34
MCHR1 Q99705 1/20 0.34
TRPA1 O75762 1/20 0.34
RAF1 P04049 1/20 0.34
EPHX2 P34913 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171970 0.89 IGF1R (0.41) IGF1RCYP3A4GAACYP2C9CYP2C19
SCHEMBL6174755 0.81 CYP3A4 (0.39) IGF1RCYP3A4GAACYP2C9CYP2C19
SCHEMBL6173179 0.80 IGF1R (0.49) IGF1R
SCHEMBL6173451 0.79 IGF1R (0.41) IGF1RCYP2C9
SCHEMBL2938872 0.75 IGF1R (0.59) IGF1R
SCHEMBL6172398 0.74 MAT2A (0.43) SCN10AMAT2ACYP3A4GAACYP2C9
SCHEMBL6174468 0.73 IGF1R (0.40) IGF1RPDE2AHDAC1
SCHEMBL6175120 0.71 IGF1R (0.45) IGF1RCYP3A4GAACYP2C9CYP2C19
SCHEMBL2934074 0.71 IGF1R (0.47) IGF1RMAT2ACYP3A4MCHR1
SCHEMBL6174756 0.70 MAT2A (0.43) SCN10AMAT2AGAAKDM5AKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed